About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 401537, 5 pages
http://dx.doi.org/10.1155/2010/401537
Research Article

Analysis of Adiponectin Gene Polymorphisms in Chinese Population with Systemic Lupus Erythematosus

1Department of Immunology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China
2Laboratory of Molecular Translational Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, China

Received 11 January 2010; Accepted 15 March 2010

Academic Editor: George C. Tsokos

Copyright © 2010 Wen Liang Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008.
  2. J. Wang, S. Yang, J. J. Chen, et al., “Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China,” Archives of Dermatological Research, vol. 298, no. 10, pp. 485–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Ardoin and D. S. Pisetsky, “Developments in the scientific understanding of lupus,” Arthritis Research and Therapy, vol. 10, no. 5, p. 218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Molokhia and P. Mckeigue, “Systemic lupus erythematosus: genes versus environment in high risk populations,” Lupus, vol. 15, no. 11, pp. 827–832, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara, “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1),” Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 286–289, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ouchi, S. Kihara, Y. Arita, et al., “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin,” Circulation, vol. 100, no. 25, pp. 2473–2476, 1999. View at Scopus
  8. J. Kawano and R. Arora, “The role of adiponectin in obesity, diabetes, and cardiovascular disease,” Journal of the CardioMetabolic Syndrome, vol. 4, no. 1, pp. 44–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Li, H. J. Shin, E. L. Ding, and R. M. Van Dam, “Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 302, no. 2, pp. 179–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. P. Chung, A. G. Long, J. F. Solus, et al., “Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis,” Lupus, vol. 18, no. 9, pp. 799–806, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. H. Rovin, H. Song, L. A. Hebert, et al., “Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus,” Kidney International, vol. 68, no. 4, pp. 1825–1833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. H. Rovin, D. J. Birmingham, H. N. Nagaraja, C. Y. Yu, and L. A. Hebert, “Biomarker discovery in human SLE nephritis,” Bulletin of the NYU Hospital for Joint Diseases, vol. 65, no. 3, pp. 187–193, 2007. View at Scopus
  13. M. Adamczak, A. Wiecek, T. Funahashi, J. Chudek, F. Kokot, and Y. Matsuzawa, “Decreased plasma adiponectin concentration in patients with essential hypertension,” American Journal of Hypertension, vol. 16, no. 1, pp. 72–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Zoccali, F. Mallamaci, G. Tripepi, et al., “Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 134–141, 2002. View at Scopus
  15. A. G. Comuzzie, T. Funahashi, G. Sonnenberg, et al., “The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 9, pp. 4321–4325, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Takahashi, Y. Arita, K. Yamagata, et al., “Genomic structure and mutations in adipose-specific gene, adiponectin,” International Journal of Obesity, vol. 24, no. 7, pp. 861–868, 2000. View at Scopus
  17. I. M. Heid, P. Henneman, A. Hicks, et al., “Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals,” Atherosclerosis, vol. 208, no. 2, pp. 412–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Mohammadzadeh and N. Zarghami, “Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 69, no. 7, pp. 764–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Li, R. Wu, and J. Zhao, “Adiponectine gene +45T/G and +276G/T polymorphism and antipsychotic-induced weight gain,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 34, no. 8, pp. 693–696, 2009. View at Scopus
  20. K. Tsuzaki, K. Kotani, N. Nagai, et al., “Adiponectin gene single-nucleotide polymorphisms and treatment response to obesity,” Journal of Endocrinological Investigation, vol. 32, no. 5, pp. 395–400, 2009. View at Scopus
  21. L. Foucan, N. Ezourhi, S. Maimaitiming, et al., “Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent,” Obesity. In press. View at Publisher · View at Google Scholar · View at Scopus
  22. E. M. Tan, A. S. Cohen, J. F. Fries, et al., “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Scopus
  23. W.-S. Yang and L.-M. Chuang, “Human genetics of adiponectin in the metabolic syndrome,” Journal of Molecular Medicine, vol. 84, no. 2, pp. 112–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. De Sanctis, M. Zabaleta, N. E. Bianco, J. V. Garmendia, and L. Rivas, “Serum adipokine levels in patients with systemic lupus erythematosus,” Autoimmunity, vol. 42, no. 4, pp. 272–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K.-E. Sada, Y. Yamasaki, M. Maruyama, et al., “Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus,” Journal of Rheumatology, vol. 33, no. 8, pp. 1545–1552, 2006. View at Scopus
  26. W.-S. Yang, P.-L. Tsou, W.-J. Lee, et al., “Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity,” Journal of Molecular Medicine, vol. 81, no. 7, pp. 428–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Kara, P. Boutin, Y. Mori, et al., “Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population,” Diabetes, vol. 51, no. 2, pp. 536–540, 2002. View at Scopus
  28. T. I. Pollin, K. Tanner, J. R. O'Connell, et al., “Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene,” Diabetes, vol. 54, no. 1, pp. 268–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. S. Mantzoros, C. J. Williams, J. E. Manson, J. B. Meigs, and F. B. Hu, “Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women,” American Journal of Clinical Nutrition, vol. 84, no. 2, pp. 328–335, 2006. View at Scopus
  30. C. S. Mantzoros, T. Li, J. E. Manson, J. B. Meigs, and F. B. Hu, “Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 8, pp. 4542–4548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Yu, X. Ye, J. Wang, et al., “Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people,” Circulation, vol. 119, no. 23, pp. 2969–2977, 2009. View at Publisher · View at Google Scholar · View at Scopus